Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07852884 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

First-Line Systemic Therapies in Advanced Renal Cell Carcinoma in Spain

Name: First-Line Systemic Therapies in Advanced Renal Cell Carcinoma in Spain — clinical trial record (NCT07852884)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: INSPIRE-RCC

StatusActive, Not Recruiting

PhaseNot specified

SponsorBristol-Myers Squibb

Started2026-07-15

View on ClinicalTrials.gov ↗

Bristol-Myers Squibb

311 trials monitored

See 15 trials at risk

Kidney Cancer

770 trials monitored

See 52 trials at risk

This retrospective observational study will use anonymized electronic medical records from the BIG-PAC® database to describe outcomes and treatment management for adults in Spain with advanced or metastatic renal cell carcinoma who start first-line systemic therapy.

Trial Details

NCT Number	NCT07852884
Lead Sponsor	Bristol-Myers Squibb
Conditions	Renal Cell Carcinoma (RCC)
Enrollment	1,200 participants
Start Date	2026-07-15
Primary Completion	2026-09-01 (estimated)
Study Completion	2026-12-01 (estimated)
Updated on ClinicalTrials.gov	2026-10-01